Aorta Positioned Circulatory Assist Pumps

Second Heart Assist Inc. is focused on developing innovative technologies aimed at improving the quality of life for patients suffering from heart failure. Their primary products include the "Whisper" catheter-based pump and the "Freedom" wireless power device platform. The Whisper device is designed for various cardiovascular applications, including Percutaneous Coronary Intervention (PCI), Acute Decompensated Heart Failure (ADHF), and Cardiogenic Shock (CS). It features a collapsible stent pump design that allows for minimally invasive placement in the aorta, providing high flow rates while minimizing risks associated with mechanical breakdown and hemolysis. The device's unique design also addresses common complications seen with existing circulatory assist devices, such as thrombosis and unstable positioning.

The Freedom platform complements the Whisper device by offering wireless power for chronic outpatient therapy, enabling patients to receive continuous support for heart failure and cardio-renal syndrome. This platform is particularly beneficial for patients who require long-term circulatory assistance but are not candidates for heart transplants. Both technologies utilize advanced materials and designs to enhance patient comfort and safety, including a thrombosis-resistant material and a pulsatile flow mechanism that reduces the risk of blood cell damage. Overall, Second Heart Assist's innovations aim to provide effective, minimally invasive solutions for managing heart failure and improving patient outcomes.

United States

Second Heart Assist Inc. is a medtech startup company that will revolutionize the treatment of chronic heart failure (HF). With its novel aortic stent pump technologies, Second Heart will enhance the lives of millions who suffer from chronic HF worldwide.

Second Heart Assist Inc.

Company Details